Voyageur Pharmaceuticals reaches first iodine study milestone, receives $1 million from Bayer
AI Summary- Voyageur Pharmaceuticals reached the first milestone in its iodine production feasibility study.
- Voyageur received a $1 million payment after reaching the milestone.
- Voyageur’s Houston team completed the demonstration required for the milestone.